We are live on ! Find out more
RI

RTW Investments Portfolio holdings

AUM $10B
1-Year Est. Return 135.35%
This Fund
S&P 500
This Quarter Est. Return
+25.66%
1 Year Est. Return
+135.35%
3 Year Est. Return
+383.62%
5 Year Est. Return
+523.94%
10 Year Est. Return
+15,981.64%
AUM
$6.77B
AUM Growth
+$373M
Cap. Flow
-$163M
Cap. Flow %
-2.41%
Top 10 Hldgs %
45.13%
Holding
79
New
15
Increased
25
Reduced
7
Closed
10

Top Buys

Rank Stock Value
1
SYK icon
Stryker
SYK
+$108M
2
IMTX icon
Immatics
IMTX
+$99.3M
3
MRUS
Merus
MRUS
+$70.4M
4
DYN icon
Dyne Therapeutics
DYN
+$69.9M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$63.8M

Top Sells

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$398M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$314M
3
CLDX icon
Celldex Therapeutics
CLDX
+$137M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$98.5M
5
VCEL icon
Vericel Corp
VCEL
+$70.4M

Sector Composition

Rank Sector Weight
1 Healthcare 99.98%
2 Financials 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SWTX
76
DELISTED
SpringWorks Therapeutics
SWTX
– –
-625,000
Closed -$22.8M
TNGX icon
77
Tango Therapeutics
TNGX
$4.41B
– –
-1,966,752
Closed -$19.5M
SIEN
78
DELISTED
Sientra, Inc.
SIEN
– –
-81,016
Closed -$49.4K
MRTX
79
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-6,768,514
Closed -$398M
1 2 3
4

Similar funds

HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
IIM
INTECH Investment Management West Palm Beach, Florida $10.2B AUM 28.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

RTW Investments's Q1 2024 Portfolio in Review

As of Q1 2024, RTW Investments held 79 positions worth $6.77B, up 5.8% from $6.4B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

RTW Investments's Q1 2024 filing shows 15 new, 25 increased, 7 reduced and 10 closed positions. Its largest new stake was Stryker: 321,000 shares worth $115M. The largest sale was Mirati Therapeutics, Inc. Common Stock, an estimated $398M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier, followed by Financials.

  • RTW Investments's largest Q1 2024 buy was Stryker: 321,000 shares worth $115M.
  • RTW Investments added most to Immatics in Q1 2024, an estimated $99.3M increase.
  • RTW Investments's biggest Q1 2024 reduction was Madrigal Pharmaceuticals, cutting an estimated $98.5M.
  • RTW Investments fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $398M.
  • RTW Investments's ten largest holdings make up 45% of its $6.77B portfolio in Q1 2024.
  • RTW Investments opened 15 new positions and closed 10 in Q1 2024.
  • RTW Investments's portfolio value rose 5.8% quarter-over-quarter to $6.77B.

Based on RTW Investments's 13F filing for Q1 2024, filed 15 May 2024.